Received Feb 4, 2026
| Type | Name | Manufacturer | Dose | Lot | Route / Site |
|---|---|---|---|---|---|
| VARZOS | ZOSTER (NO BRAND NAME) | UNKNOWN MANUFACTURER | 2 | UNK | — |
Flu for 3 days; This non-serious case was reported by a consumer via interactive digital media and described the occurrence of influenza in a patient who received Herpes zoster (Shingles vaccine) for prophylaxis. On an unknown date, the patient received the 2nd dose of Shingles vaccine. On an unknown date, an unknown time after receiving Shingles vaccine, the patient experienced influenza (Verbatim: Flu for 3 days). The outcome of the influenza was resolved (duration 3 days). It was unknown if the reporter considered the influenza to be related to Shingles vaccine. It was unknown if the company considered the influenza to be related to Shingles vaccine. Additional Information: GSK Receipt Date: 20-JAN-2026 This case was reported by a patient via interactive digital media. It was reported that the shot itself was not really painful, but the patient had full-blown flu for three days after both the first shot and the second shot. That was a common side effect. The case is linked to the case US2026AMR011176 (1st dose). The batch number was not provided, and we are unable to contact the reporter.; Sender's Comments: US-GSK-US2026AMR011176:Case for 1st dose